| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.007 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.089 | 0.008 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.009 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.087 | 0.009 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.071 | 0.01 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.01 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.01 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.082 | 0.01 |